Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984–2002
作者： C. Herder , J. Baumert , B. Thorand , W. Koenig , W. de Jager
DOI: 10.1007/S00125-006-0190-Y
关键词:
摘要: Aims/hypothesis The chemokines monocyte chemoattractant protein-1 (MCP-1), IL-8 and interferon-γ-inducible protein-10 (IP-10) are released by adipocytes appear to be involved in atherosclerosis. We hypothesised that these may risk factors for the development of type 2 diabetes.
springer.com
paperity.org参考文章(33)
Henri Darquennes, Marcel Kornitzer, Luc Berghmans, R. Payen, Raphaël Lagasse, Michèle Dramaix Wilmet, The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): A major international Collaboration Journal of Clinical Epidemiology. ,vol. 41, pp. 105- 114 ,(1988)
Craig Gerard, Barrett J. Rollins, Chemokines and disease Nature Immunology. ,vol. 2, pp. 108- 115 ,(2001) , 10.1038/84209
Winston L Hutchinson, Wolfgang Koenig, Margit Fröhlich, Malte Sund, Gordon D O Lowe, Mark B Pepys, Immunoradiometric Assay of Circulating C-Reactive Protein: Age-related Values in the Adult General Population Clinical Chemistry. ,vol. 46, pp. 934- 938 ,(2000) , 10.1093/CLINCHEM/46.7.934
E. Simeoni, M. M. Hoffmann, B. R. Winkelmann, J. Ruiz, S. Fleury, B. O. Boehm, W. M�rz, G. Vassalli, Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus. Diabetologia. ,vol. 47, pp. 1574- 1580 ,(2004) , 10.1007/S00125-004-1494-4
J. C. Pickup, Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. ,vol. 27, pp. 813- 823 ,(2004) , 10.2337/DIACARE.27.3.813
William E. Barlow, Robust variance estimation for the case-cohort design. Biometrics. ,vol. 50, pp. 1064- ,(1994) , 10.2307/2533444
Kathryn E. Wellen, Gökhan S. Hotamisligil, Obesity-induced inflammatory changes in adipose tissue Journal of Clinical Investigation. ,vol. 112, pp. 1785- 1788 ,(2003) , 10.1172/JCI20514
S. Nomura, A. Shouzu, S. Omoto, M. Nishikawa, S. Fukuhara, Significance of chemokines and activated platelets in patients with diabetes. Clinical and Experimental Immunology. ,vol. 121, pp. 437- 443 ,(2000) , 10.1046/J.1365-2249.2000.01324.X
Aruna D Pradhan, JoAnn E Manson, Nader Rifai, Julie E Buring, Paul M Ridker, None, C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus JAMA. ,vol. 286, pp. 327- 334 ,(2001) , 10.1001/JAMA.286.3.327
S. Müller, S. Martin, W. Koenig, P. Hanifi-Moghaddam, W. Rathmann, B. Haastert, G. Giani, T. Illig, B. Thorand, H. Kolb, Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptors Diabetologia. ,vol. 45, pp. 805- 812 ,(2002) , 10.1007/S00125-002-0829-2